Alembic Pharmaceuticals Limited is a leading pharmaceutical company that specializes in the development, manufacturing, and marketing of pharmaceutical products in both India and international markets. With a wide range of offerings, the company provides active pharmaceutical ingredients and formulations to cater to various therapeutic areas including cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, and anti-diabetic. Additionally, Alembic Pharmaceuticals Limited exports its high-quality products. Established in 1907, the company is headquartered in Vadodara, India.
Navigation section
Alembic Pharmaceuticals Limited
- 1,109.00 6.45(0.59%) 1,103.75 0.55(0.05%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 1,093.45 1,094.90 | 1,118.90 1117.40 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 746.00 (21-Dec-2023) 744.95 (21-Dec-2023) | 1,303.90 (09-Oct-2024) 1,296.15 (09-Oct-2024) |
- Open
- 1,105.05 1,112.90
- Previous Close
- 1,102.55 1,103.20
- Volume
- 0.58
- Total Traded value
- 6.46 (₹ Lakhs)
- Upper circuit
- 1,323.05 1,057.30
- Lower circuit
- 882.05 704.90
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 0 | 0 |
| Bid Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
| Ask Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
Fundamentals
| Market Cap: | ₹217.99 Cr |
| PE Ratio (TTM): | 27.92 |
| PB Ratio: | 4.31 |
| Industry P/E: | 34.10 |
| Debt to Equity: | - |
| ROE: | 15.44 |
| EPS (TTM): | 39.53 |
| Book Value: | 22.77 |
| Face Value: | 2.00 |
Financials
| Sep, 2022 | Sep, 2023 | Sep, 2022 | Sep, 2022 | Sep, 2023 | |
|---|---|---|---|---|---|
| Revenue | 646.43 Cr | 251.46 Cr | 136.95 Cr | 555.53 Cr | 1,478.84 Cr |
| Profit | 69.38 Cr | 32.86 Cr | 57.51 Cr | 91.57 Cr | 133.84 Cr |
| Expense | 578.68 Cr | 213.66 Cr | 86.08 Cr | 415.54 Cr | 1,353.95 Cr |
| Comprehensive income | 69.46 Cr | 37.55 Cr | 57.90 Cr | 91.56 Cr | 131.83 Cr |
| EPS | 1.89 | 26.20 | 7.52 | 22.04 | 6.81 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Alembic Pharmaceuticals Limited | Sep, 2011 Sep, 2011 | Pharmaceuticals Pharmaceuticals | APLLTD APLLTD |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Alembic Pharmaceuticals Limited FAQ's
What is the range of today's stock performance for Alembic Pharmaceuticals Limited?
Today's stock performance witnessed a fluctuation from a minimum of 1,093.45 on the NSE (National Stock Exchange) to a maximum of 1,118.90. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 1,094.90 to a high of 1,117.40.
What are the 52-week low and high values for Alembic Pharmaceuticals Limited?
The stock's performance over the past 52 weeks reveals a low of 746.00 (occurred on 21-Dec-2023) and a high of 1,303.90 (achieved on 09-Oct-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 744.95 (on 21-Dec-2023), and the 52-week high is 1,296.15 (on 09-Oct-2024).
What was the opening and previous closing prices for Alembic Pharmaceuticals Limited?
The stock's performance over the past 52 weeks reveals a low of 746.00 (occurred on 21-Dec-2023) and a high of 1,303.90 (achieved on 09-Oct-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 744.95 (on 21-Dec-2023), and the 52-week high is 1,296.15 (on 09-Oct-2024).
What is the total volume and traded value for Alembic Pharmaceuticals Limited for the day?
The total volume is 1, and the total traded value is 6.46 (₹ Lakhs).
What are the upper and lower circuit limits for Alembic Pharmaceuticals Limited?
The upper circuit limit is 1,323.05, and the lower circuit limit is 882.05.
What is the market cap and PE ratio for Alembic Pharmaceuticals Limited?
The market cap is ₹217.99 Cr, and the PE ratio (TTM) is 33.57.
What is the PB ratio, industry P/E, and debt to equity ratio for Alembic Pharmaceuticals Limited?
The PB ratio is 48.70, industry P/E is 34.10 .
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Alembic Pharmaceuticals Limited?
ROE is 15.44, EPS is 39.53, book value is 22.77
What are the revenue and profit figures for the latest quarter and previous quarters for Alembic Pharmaceuticals Limited?
In Sep 2022, Revenue is ₹6464300000, and Profit is ₹693800000. In Sep 2023, Revenue is ₹2514570000.00, and Profit is ₹328630000.00.
When was Alembic Pharmaceuticals Limited listed, and what industry does it belong to?
The company, Alembic Pharmaceuticals Limited, was listed in Sep 2011 and belongs to the Pharmaceuticals industry. Its NSE symbol is APLLTD.
What is the current shareholding pattern of the Alembic Pharmaceuticals Limited?
As of latest available update, promoters hold 69.61%, the public holds 30.39%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 29
- Threads
- 96
